Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

ERISA Recap: 6 Developments To Remember From Feb. No Photo Available

Kellie Mejdrich

The Second Circuit refused to boot a former Luxottica worker's proposed class claims into solo arbitration, a Texas federal judge decl... (more story)

Pharma In Uphill Fight With Contract Pharmacy Laws No Photo Available

Mark Payne

Silence in the federal law governing the 340B discount drug program on the issue of contract pharmacies is working against drugmakers ... (more story)

3 Argument Sessions For Healthcare Attys To Watch In March No Photo Available

Gianna Ferrarin

Ohio defends a gender transition ban and Janssen seeks to shed a $1.64 billion False Claims Act judgment. Law360 looks at the healthca... (more story)